Clinical Trial Update: Abraxane and Temodar Plus Genasense in Advanced Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Abraxane (paclitaxel protein-bound particles), Temodar (temozolomide), and Genasense (oblimersen) in advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Genasense (oblimersen)
• Temodar (Temozolomide)

Snippet

Sponsor: Genta Incorporated | Conditions: Melanoma | Phase 1 | Status: UNKNOWN